Log in or Sign up for Free to view tailored content for your specialty!
Endocrinology News
VIDEO: ‘Buckle up’ for new anti-obesity medications coming down the pipeline
DENVER — The development of several new anti-obesity medications could improve availability for patients, according to a speaker at the Obesity Medicine Association’s conference.
Do not underestimate the power of ‘move more and sit less’ guideline, speaker says
DENVER —Exercise “pretty much improves everything” from metabolic health to musculoskeletal, cardiovascular, pulmonary, mental, sexual and cognitive health, an expert said.
Log in or Sign up for Free to view tailored content for your specialty!
Fracture risk elevated for children of mothers with prepregnancy or gestational diabetes
Risk for incident fracture is higher for children born to mothers with type 2 diabetes or gestational diabetes compare with those whose mothers did not have diabetes, according to data published in the Journal of Bone and Mineral Research.
VIDEO: ‘It’s an exciting time’ to provide obesity care
DENVER — More than 1,200 clinicians are coming together to learn more about obesity at the Obesity Medicine Association’s 2024 conference, according to a speaker here.
Adults receiving semaglutide as their first obesity medication lose more weight
Adults who previously used an obesity medication before receiving semaglutide lost less body weight at 12 months than those who did not use an obesity medication before semaglutide, according to study findings.
Federal Trade Commission bans most noncompete agreements
In a 3-2 vote, the Federal Trade Commission passed a final rule that bans new noncompete agreements with all workers in for-profit organizations.
Low level of regret for treatment decision for most adults with low-risk thyroid cancer
Adults with low-risk papillary thyroid cancer reported low levels of decision regret for their disease management choice at 1 year, regardless of whether they chose active surveillance or surgery, according to findings published in Thyroid.
ACP: Use GLP-1 agonists or SGLT-2 inhibitors as add-on therapies for type 2 diabetes
BOSTON — New recommendations from ACP on type 2 diabetes treatment include adding a GLP-1 agonist or SGLT-2 inhibitor to therapy for patients who have inadequate glycemic control, the organization announced.
Low-fat vegan diet tied to improved insulin sensitivity for adults with type 1 diabetes
Eating a low-fat vegan diet induced a greater improvement in insulin sensitivity and a larger reduction in total daily insulin dose than a portion-controlled diet for adults with type 1 diabetes, according to study findings.
Investigational Cushing’s syndrome medication reduces BP, glucose in open-label trial
Adults with endogenous Cushing’s syndrome had reductions in blood pressure and glucose at 22 weeks of treatment with a selective cortisol modulator, according to topline results from the open-label portion of the GRACE phase 3 trial.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read